Discover 1,123 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Alabama provides a diverse range of research opportunities for healthy volunteers and individuals with specific health conditions. Leading research centers in Birmingham, Montgomery, and Mobile are seeking participants, offering access to innovative treatments and cutting-edge medical care.
Filter
1
Filter results
Results: 1,123
An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
for
Hyperkalaemia
Location: Montreal, Baltimore MD, Columbia SC, Cincinnati OH,
Sponsor: AstraZeneca
Sex: All
Age: 0 - 18
Code: NCT03813407
Phase 3, Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Brewer ME, Burlington MA, Manchester NH, Worcester MA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase 2, Recruiting
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
for
Cervical Cancer
Location: Birmingham AL, Centreville AL
Sponsor: University of Alabama at Birmingham
Sex: Female
Age: 21 - 65
Code: NCT04093388
Recruiting
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
for
Neoplasms, Brain, Glioblastoma Multiforme,
Location: Birmingham AL, St Louis MO, Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 3 - 22
Code: NCT03911388
Phase 1, Recruiting
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
for
Acute Kidney Injury
Location: New Haven CT, Baltimore MD, Weston FL, Cleveland OH,
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT05805709
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testimonials and Navigation in Rheumatology
for
Rheumatologic Disease, Autoimmune Diseases
Location: Boston MA, Worcester MA, Birmingham AL, Evanston IL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT06469788
Recruiting
Effect of a DASH-Style Diet on Urinary Risk Factors for Kidney Stone Disease
for
Kidney Stone
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 19 - 70+
Code: NCT06210009
Recruiting
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
Location: St. John's, Moncton, Boston MA, Bristol CT, Hamden CT,
Sponsor: Vedanta Biosciences, Inc.
Sex: All
Age: 12+
Code: NCT06237452
Phase 3, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: St. John's, Halifax, Bangor ME, Scarborough ME,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase 3, Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase 3, Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Boston MA, Burlington MA, Norfolk MA, Hartford CT,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06433752
Recruiting
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
for
Ovarian Carcinoma
Location: Portland ME, Scarborough ME, Boston MA, Providence RI,
Sponsor: NRG Oncology
Sex: Female
Age: 35 - 50
Code: NCT04251052
Recruiting
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Mira Road, Halifax, Bangor ME, Fall River MA, Boston MA,